Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Taft

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Biopharmaceutics & Drug Disposition|May 6, 2017
Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populationsVamshi Krishna Jogiraju, Suvarchala Avvari, Rakesh Gollen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 2006
Effects of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and Lamivudine in the isolated perfused rat kidneyTomoko Nakatani-Freshwater, Mariana Babayeva, Aruna Dontabhaktuni, et al.
Drug Metabolism and Pharmacokinetics|February 9, 2021
Physiologically based pharmacokinetic modeling of altered tizanidine systemic exposure by CYP1A2 modulation: Impact of drug-drug interactions and cigarette consumptionVamshi Krishna Jogiraju, Tycho Heimbach, Yuliana Toderika, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 12, 2011
Renal excretion of apricitabine in rats: ex vivo and in vivo studiesMariana Babayeva, Susan Cox, Michael P White, et al.
The Journal of Pharmacy and Pharmacology|June 7, 2013
Determination of intestinal permeability of rigosertib (ON 01910.Na, Estybon): correlation with systemic exposureMichael P White, Mariana Babayeva, David R Taft, et al.
Biology of Reproduction|June 22, 2000
Increased expression of insulin-like growth factor binding protein-1 during induced regression of bovine corpora luteaB L Sayre, R Taft, E K Inskeep, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Characterization of pentamidine excretion in the isolated perfused rat kidneyNagaraju R Poola, Michelle Kalis, Fotios M Plakogiannis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 1997
Application of a first-pass effect model to characterize the pharmacokinetic disposition of venlafaxine after oral administration to human subjectsD R Taft, G R Iyer, L Behar, et al.
Journal of Clinical Pharmacology|May 4, 2021
Application of Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling in Preterm Neonates to Guide Gentamicin Dosing Decisions and Predict Antibacterial EffectHarshith Neeli, Nazeeh Hanna, Khaled Abduljalil, et al.
Organic Letters|May 5, 2006
Chiral silanes via asymmetric hydrosilylation with catalytic CuHBruce H Lipshutz, Naoki Tanaka, Benjamin R Taft, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Biopharmaceutics & Drug Disposition|May 6, 2017
Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populationsVamshi Krishna Jogiraju, Suvarchala Avvari, Rakesh Gollen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 24, 2006
Effects of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and Lamivudine in the isolated perfused rat kidneyTomoko Nakatani-Freshwater, Mariana Babayeva, Aruna Dontabhaktuni, et al.
Drug Metabolism and Pharmacokinetics|February 9, 2021
Physiologically based pharmacokinetic modeling of altered tizanidine systemic exposure by CYP1A2 modulation: Impact of drug-drug interactions and cigarette consumptionVamshi Krishna Jogiraju, Tycho Heimbach, Yuliana Toderika, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 12, 2011
Renal excretion of apricitabine in rats: ex vivo and in vivo studiesMariana Babayeva, Susan Cox, Michael P White, et al.
The Journal of Pharmacy and Pharmacology|June 7, 2013
Determination of intestinal permeability of rigosertib (ON 01910.Na, Estybon): correlation with systemic exposureMichael P White, Mariana Babayeva, David R Taft, et al.
Biology of Reproduction|June 22, 2000
Increased expression of insulin-like growth factor binding protein-1 during induced regression of bovine corpora luteaB L Sayre, R Taft, E K Inskeep, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Characterization of pentamidine excretion in the isolated perfused rat kidneyNagaraju R Poola, Michelle Kalis, Fotios M Plakogiannis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 1997
Application of a first-pass effect model to characterize the pharmacokinetic disposition of venlafaxine after oral administration to human subjectsD R Taft, G R Iyer, L Behar, et al.
Journal of Clinical Pharmacology|May 4, 2021
Application of Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling in Preterm Neonates to Guide Gentamicin Dosing Decisions and Predict Antibacterial EffectHarshith Neeli, Nazeeh Hanna, Khaled Abduljalil, et al.
Organic Letters|May 5, 2006
Chiral silanes via asymmetric hydrosilylation with catalytic CuHBruce H Lipshutz, Naoki Tanaka, Benjamin R Taft, et al.
Pageof 9